Reza Shojaei: Public–Private Partnerships are Essential to Expanding Plasma Collection Capacity
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn:
“This article highlights Canadian Blood Services’ efforts to strengthen Canada’s plasma self-sufficiency and reduce reliance on the U.S. for critical plasma-derived medicines.
Reaching meaningful self-sufficiency, including a practical target of at least 50% domestic supply, will require coordinated action across the sector.
Public–private partnerships are essential to expanding plasma collection capacity, enabling investment in infrastructure, and ensuring long-term access to life-saving therapies for Canadians.
Canadian Blood Services’ openness to collaborative models reflects a pragmatic, patient-centred approach to a growing national challenge. Building a resilient plasma system depends on shared responsibility, complementary capabilities, and aligned policy frameworks across public and private stakeholders.
This represents an important step toward a more secure and sustainable ecosystem for plasma-derived products in Canada.”
Title: Canadian Blood Services reducing reliance on U.S. for life-changing plasma drugs

Read full article here.
Get the latest insights with Hemostasis Today.
-
Nov 13, 2026, 16:17Shailendra Singh: Bombay Hospital Jaipur Inaugurates New Facility with Voluntary Blood Donation Camp
-
Nov 13, 2026, 16:10Minka Zivkovic: UMC Utrecht Announces Research Analyst Vacancy in Thrombosis and Haemostasis
-
Nov 13, 2026, 16:02Rounak Dubey: Elsevier’s Upcoming Handbook Explores Digitalization in Transfusion Medicine
-
Nov 13, 2026, 15:50Maha Othman: CanVECTOR 2026 Highlights Research on Immunothrombosis and Cancer-Associated Thrombosis
-
Nov 13, 2026, 15:48Cedric Hermans: Advances in Gene Therapy for Haemophilia A
-
Nov 13, 2026, 15:45Strengthens Global Collaboration in Thrombosis and Hemostasis for 2027 – ISTH
-
Nov 13, 2026, 15:42David McIntosh: The Global Blood Shortage Crisis and the Urgent Need for National Action
-
Nov 13, 2026, 15:41JTH Highlights Future Directions in Thromboprophylaxis for Hospitalized Children
-
Nov 13, 2026, 15:21Wolfgang Miesbach։ Gene Therapy for Haemophilia B Is Cheaper Than Lifelong Factor IX Prophylaxis in Sweden